1. Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension
- Author
-
Rachel Dankner, Angela Chetrit, Michael Bergman, and Jesse Roth
- Subjects
medicine.medical_specialty ,endocrine system diseases ,business.industry ,Endocrinology, Diabetes and Metabolism ,Mortality rate ,nutritional and metabolic diseases ,Physiology ,medicine.disease ,Impaired fasting glucose ,Impaired glucose tolerance ,Endocrinology ,Internal medicine ,Diabetes mellitus ,Cohort ,Internal Medicine ,medicine ,Prediabetes ,Metabolic syndrome ,business ,Glycemic - Abstract
Background We describe the relationship between dysglycemia and long-term mortality and elucidate the relationship between blood glucose levels during an oral glucose tolerance test (OGTT) and haemoglobin A1 (HbA1) and mortality. Methods A cohort of 1410 individuals was followed for 33 years since 1980. Fasting and post-OGTT glucose parameters were used to categorize the cohort according to baseline glycemic status. Results The mortality rate increased from 43% in normoglycemic individuals to 53.3, 61.7, 72.9 and 88.0% in those with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), IFG/IGT and diabetes, respectively. The highest mortality rate, compared with the normoglycemic category, was observed in individuals with IFG/IGT and diabetes according to a Cox proportional hazard model (HR = 1.38, 95%CI 1.10–1.74 and HR = 2.14, 95%CI 1.70–2.70, respectively), followed by individuals with IGT and IFG, but this did not reach statistical significance. We speculate that the IFG group may represent a mixture of individuals en route from normal to the next two categories as well as another cohort whose glucose levels are stably set at the upper reaches of the normal distribution. Significant differences were found between 1 and 2 h glucose values (p
- Published
- 2014
- Full Text
- View/download PDF